Status:
TERMINATED
Ideal Time of Oxytocin Infusion During Cesarean Section
Lead Sponsor:
Loyola University
Conditions:
Blood Loss, Surgical
Postpartum Hemorrhage
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
This study will evaluate if the timing of oxytocin administration in cesarean deliveries will affect the amount of maternal blood loss. Half of participants will receive oxytocin after delivery of the...
Detailed Description
Oxytocin is a routinely administered medication for both vaginal and cesarean deliveries in the third stage of labor, as part of standard of care in the United States. This medication helps to reduce ...
Eligibility Criteria
Inclusion
- Women undergoing cesarean section at Loyola Hospital
- Women who read and speak the English and/or Spanish language
- Women age 18 or older
Exclusion
- Women who deliver vaginally
- Gestation under 37 weeks and 0 days
- Women with coagulopathies
- Multiple gestation pregnancies
- Antepartum hemorrhage for example abruption
- Placental abnormalities for example previa, accreta
Key Trial Info
Start Date :
September 13 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 24 2020
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT03246919
Start Date
September 13 2017
End Date
February 24 2020
Last Update
June 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Loyola University Medical Center
Maywood, Illinois, United States, 60153